REVELIO Planned Participant-Level Validation to Separate New Drivers From Repeated Sensor Windows

The REVELIO protocol plans to keep each participant’s data entirely within either training or testing during model validation. This addresses a specific risk: repeated sensor windows from one driver can make an apparent test less independent than it looks.

Many windows do not create many drivers

The planned high-frequency data will be divided into sessions, scenarios and time windows. Windows from the same person can share driving habits and physiological characteristics. If they appeared on both sides of a model evaluation, performance could partly reflect recognition of that person rather than generalization to an unseen driver.

The protocol specifies grouped evaluation

The authors propose leave-one-subject-out or equivalent grouped cross-validation. Preprocessing and feature selection are to be learned within training data and applied unchanged to held-out data. Nested procedures are planned where feasible. These are methodological commitments in a protocol, not evidence that a completed model achieved a particular accuracy.

Internal separation does not complete external validation

Holding out participants helps assess performance within the recruited sample. It does not establish transportability to new roads, devices, populations or competing causes of poor driving. The publication supplies a reviewable strategy for limiting information leakage. A future result should be assessed against what was actually implemented, while retaining the distinction between participant-level internal validation and independent external testing.

Related analysis: the source’s broader findings and limitations.

Research cited

Deuber and colleagues (2026). Protocol for the REVELIO test-track pilot study: A randomised, controlled, single-centre trial in healthy recreational cannabis users investigating real-time in-vehicle detection of cannabis-impaired driving.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

The CBD Scan Trial Used Equal Allocation Despite Planning a Two-to-One Ratio

The scan-anxiety study ultimately randomized twenty-five participants to each treatment. The paper disclosed that its original sample-size plan anticipated a two-to-one allocation instead. The discrepancy concerned the allocation ratio The central registrar inadvertently implemented a one-to-one scheme rather than the originally intended unequal ratio. Participants still underwent randomized assignment, and…

Spread the love

Read Article: The CBD Scan Trial Used Equal Allocation Despite Planning a Two-to-One Ratio

Only Six Participants Had Severe Baseline Anxiety in the CBD Scan Trial

The scan-anxiety trial stratified randomization by baseline anxiety severity, but only six participants were in its severe category. Stratification did not supply enough data for a reliable severe-anxiety subgroup analysis. The strata helped organize allocation Participants were assigned within GAD-7 categories covering mild-to-moderate and severe anxiety. Of the fifty women…

Spread the love

Read Article: Only Six Participants Had Severe Baseline Anxiety in the CBD Scan Trial

The CBD Scan-Anxiety Trial Measured Prescan Anxiety, Not Anxiety During the Scan

The trial’s acute anxiety assessment occurred after CBD dosing but generally before the scheduled cancer scan. It did not directly measure whether CBD reduced distress inside the scanner. The two timing intervals were different Participants received the study drug within 48 hours before a tumor-assessment scan. Anxiety was reassessed two…

Spread the love

Read Article: The CBD Scan-Anxiety Trial Measured Prescan Anxiety, Not Anxiety During the Scan

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us